VOR

2.48% -0.0238

시간 외 거래: .93 -0.0042 -0.45%

보 바이오파마 (VOR)

Relative Volume:

보 바이오파마 Stock (VOR) Company Profile

Vor Biopharma Inc

617-655-6580

100 CAMBRIDGEPARK DRIVE, CAMBRIDGE

최신 SEC 제출 서류

VOR's Discussions on Twitter

보 바이오파마 Stock (VOR) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2022-07-26	개시	Wedbush	Outperform
2022-04-27	개시	Goldman	Neutral
2021-12-17	개시	H.C. Wainwright	Buy
2021-12-03	개시	Robert W. Baird	Outperform
2021-12-02	개시	Oppenheimer	Outperform
2021-10-19	개시	JMP Securities	Mkt Outperform
2021-03-25	개시	B. Riley Securities	Buy
2021-03-03	개시	Barclays	Overweight
2021-03-03	개시	Evercore ISI	Outperform
2021-03-02	개시	Goldman	Sell
2021-03-02	개시	Stifel	Buy

보 바이오파마 주식(VOR)의 최신 뉴스

보 바이오파마 (VOR) 재무 분석

보 바이오파마 (VOR)

보 바이오파마 Stock (VOR) Company Profile

보 바이오파마 Stock (VOR) Upgrades & Downgrades

보 바이오파마 주식(VOR)의 최신 뉴스

Vornado Realty Trust (VNO) may enjoy gains as insiders got busy in the recent days - Knox Daily

Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Aviat Networks, Inc. for potential violations of federal securities laws - AccessWire

What to expect from VNO’s earnings report this quarter? - US Post News

President Of Verona Pharma Sold 28% Of Their Shares - Simply Wall St

Daiwa Securities Group Inc. Sells 3,155 Shares of Varonis Systems, Inc. (NASDAQ:VRNS) - Defense World

Volatus Aerospace (CVE:VOL) Stock Price Down 1.9% - Defense World

ValiRx’s Inaphaea Inks Deal with Xenopat for Cancer Research - TipRanks

Varonis Systems Inc [VRNS] Stock sold by Insider O’Boyle James for $3.83 million - Knox Daily

'V/H/S/Beyond' Is About to Put a New Director on the Map in a Very Big & Wild Way [Exclusive] - Collider

Viromed Medical AG Plans to Acquire All Shares of ActivCell Group AG by Way of a Capital Increase Against Contribution in Kind with Exclusion of Subscription Rights - Financial Post

Recent Insider Activity Suggests Potential Gains for VOXX International Corp (VOXX) - Knox Daily

Vornado Realty Trust stock outperforms competitors on strong trading day - MarketWatch

Vornado Realty Trust (NYSE:VNO) Shares Sold by Daiwa Securities Group Inc. - Defense World

Victory Capital Management Inc. Purchases 7,762 Shares of Veralto Co. (NYSE:VLTO) - Defense World

Verona Pharma PLC (VRNA) CEO David Zaccardelli Sells 600,000 Shares By GuruFocus - Investing.com Canada

California Biotech Reports Positive QOL Improvements in Program - Streetwise Reports

Wolf Popper LLP Announces Investigation on Behalf of Aviat Networks, Inc. Investors - GlobeNewswire

Biotech Co. Says New Data Show Success of Type 1 Diabetes Treatment - Streetwise Reports

Velo3D Leaves NYSE for Over-the-Counter Market—Here’s Why - 3DPrint.com

Insider Selling: Attar Eyal C., Vor Biopharma Inc [VOR] CHIEF MEDICAL OFFICER divested 14,645 shares - Knox Daily

Velo3D stock to be delisted from New York Stock Exchange; Company to begin trading on OTCQX Best Market - TCT Magazine

A better buy-in window may exist right now for Vor Biopharma Inc (VOR) - SETE News

Analytical Lens: Exploring Vor Biopharma Inc (VOR)’s Financial Story Through Ratios - The Dwinnex

VOR’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle

Vor Biopharma (NASDAQ:VOR) Will Have To Spend Its Cash Wisely - Simply Wall St

Biotech Working on 'Functional Cure' for Type 1 Diabetes - Streetwise Reports

MA Biotech Reports Positive Meeting with FDA - Streetwise Reports

Gene Editing Therapeutics Market Forecast 2024-2029: A $1 Billion Market by 2029, with a Forecasted CAGR of 147% - GlobeNewswire Inc.

How did Vor Biopharma Inc (VOR) fare last session? - US Post News

Medical Properties Trust, Inc. (NYSE:MPW) Position Trimmed by Van ECK Associates Corp - Defense World

Brokerages Set Vor Biopharma Inc. (NYSE:VOR) PT at $10.92 - MarketBeat

JMP Securities Reiterates Market Outperform Rating for Vor Biopharma (NYSE:VOR) - Defense World

HC Wainwright Reiterates “Buy” Rating for Vor Biopharma (NYSE:VOR) - Defense World

Principal Financial Group Inc. Has $10.28 Million Position in Molson Coors Beverage (NYSE:TAP) - Defense World

Thesis Gold (CVE:TAU) PT Raised to C$3.00 - Defense World

What's Going On With Penny Stock Blood Cancer-Focused Vor Biopharma On Friday? - MSN

Vor Biopharma (NYSE:VOR) Earns Market Outperform Rating from JMP Securities - MarketBeat

Vor’s stem cell transplant delays cancer relapse - BioWorld Online

Vor Biopharma Inc (VOR) Stock: A Year of Stock Market Dynamics - The InvestChronicle

Mass. Biopharma Reports Positive Data & Announces New Program - Streetwise Reports

What's Going On With Penny Stock Blood Cancer-Focused Vor Biopharma On Friday? - Benzinga

Vor Biopharma stock holds price target, buy rating on positive study data - Investing.com

Ncino Inc. [NCNO] stock for 19,355 USD was sold by Orenstein Gregory - Knox Daily

A company insider recently sold 7,500 shares of Ardelyx Inc [ARDX]. Should You Sale? - Knox Daily

CHIEF MEDICAL OFFICER Attar Eyal C. sold 14,645 shares of Vor Biopharma Inc [VOR] - Knox Daily

Gaining Ground: Vor Biopharma Inc (VOR) Closes Lower at 0.82, Down -2.37 - The Dwinnex

Baird reiterates Outperform on Vor Biopharma as trem-cel data derisks safety profile - Investing.com

Vor Bio Announces New Clinical Data from Its Ongoing Phase 1/2 VBP101 Study of Patients with Relapsed/Refractory AML Receiving trem-cel Followed by Mylotarg? - Marketscreener.com

Vor Bio reports promising AML treatment data - Investing.com India

Aqua Metals Inc [AQMS] Shares Fall Approximately -81.89% Over the Year - Knox Daily

Vor Bio reports promising AML treatment data - Investing.com

보 바이오파마 (VOR) 재무 분석

매출

순이익

현금흐름

주당 순 이익

VOR과 유사한 종목